Consumables are the line item that decides whether an aesthetic treatment is profitable, and they are also the line item most often chosen on price alone. A cannula that costs forty cents less but drags on entry costs more than the saving in a single bruised patient, and a syringe whose plunger stiffens mid-injection costs more than that in wasted filler. This is how to cost the category properly and what to demand before it ships.

(Last modified date: October 3, 2026)

The four consumables that do the work

Most aesthetic procedures are delivered through a short list of single-use items, and each one carries a specific patient-safety property rather than a general “quality” property.

Matching the consumable to the procedure

Gauge and volume should be derived from the product being injected, not from habit. Viscosity sets the bore; the anatomical plane sets the length; the delivery system sets the hub.

The failure that follows from getting this wrong is mechanical rather than microbial. A cannula chosen too fine for a dense filler will track unpredictably and deliver unevenly; a needle chosen too long for a superficial plane will do the opposite. Both look like technique errors and are actually specification errors.

What “patient-safe” means in documentary terms

Safe is not an adjective a supplier can award itself. For a United States market, consumables manufactured as medical devices fall under 21 CFR Part 820, the Quality Management System Regulation, which since 2024 has incorporated ISO 13485 by reference. Two clauses are worth naming because they produce the documents a clinic actually files: § 820.35, control of records, and § 820.45, device labelling and packaging controls.

So ask for four things per lot: the sterilization statement with method and achieved parameters; the lot-to-release traceability record; the labelling artwork for the exact catalogue number; and the expiry or shelf-life basis. If a biocompatibility assessment is claimed, ask for the report reference. The standard’s name is not the evidence; the report is.

A single-use label is a regulatory statement, not a preference. The FDA defines a single-use device as one intended for a single use, or on a single patient during a single procedure, and where such a device is reprocessed the reprocessed item must remain as safe and effective as the original. In an injectable workflow there is no reprocessing step that restores a needle’s bevel or a cannula’s tip, so the label is the specification.

A cost model with the assumptions written down

Take a clinic running 900 injectable procedures a year. Assume a consumable set of $6.50 per procedure — syringe, needle or cannula, gloves and drape — giving $5,850 a year at list price. Now add the two hidden lines that price-led purchasing creates.

Assume that a cheaper cannula increases the re-treat rate by 2%, which is 18 extra appointments at a $180 ticket, or $3,240 of chair time that earns little. Add wastage of one in fifty syringes at $2.20, or about $40 a year. The discount has to exceed roughly $3,280 a year — more than half the entire consumable spend — before the cheap option is actually cheaper. This is a model, not a measurement: the numbers to replace with your own are the re-treat rate and the chair-time value, and they are the ones that move the answer.

Storage, rotation and disposal

Consumables have a shelf life, and it is shorter in a warm damp store than the label implies. Rotate stock so the shortest expiry leaves first, keep items in their original packaging until use, and treat a damp, punctured or crushed pack as a failed barrier regardless of how the contents look. Sharps go into an approved container at the point of use, and the container is closed when it reaches the fill line rather than when someone remembers.

FAQs

What documents should arrive with each lot of consumables?

A sterilization statement with method and achieved parameters, lot-to-release traceability, the labelling artwork for the catalogue number, and the shelf-life basis. These map onto record control and labelling and packaging controls under 21 CFR Part 820.

How much do consumables actually cost per procedure?

It depends entirely on the set, but the useful figure is not the unit price, it is the unit price plus the cost of re-treatments and wastage that a poorly specified consumable creates.

Is a syringe with a Luer-lock hub always better?

Not universally, but for viscous products it removes the failure mode that matters most: separation under pressure. Match the hub to the product, not to the lowest price in the category.

Can unused consumables from a cancelled procedure be returned to stock?

Only if the sterile barrier is untouched and the item has left the treatment environment unopened. Once the outer packaging has been in the field, treat it as used.

How long can consumables be stored?

Until the labelled expiry, provided storage stays within the conditions the manufacturer states. The label is the authority; a longer shelf life claimed by a seller is not.

References

• Reprocessing of Single-Use Medical Devices, U.S. Food and Drug Administration.
• 21 CFR Part 820 — Quality Management System Regulation, eCFR.